We utilize a third-party certifying body to provide assurance that our products are manufactured under strict GMP conditions to ensure that they are safe, effective, and compliant with FDA regulations
Your doctor can offer strategies to manage them effectively and ensure you feel comfortable and supported throughout your treatment
In a landmark Phase 2 obesity trial, participants receiving the highest dose achieved: Up to ~24% average weight loss at 48 weeks Weight loss had not yet plateaued at the end of the study Potential for even greater reductions with longer treatment duration For context: Semaglutide (GLP-1): ~15% weight loss Tirzepatide (GIP + GLP-1): ~2123% weight loss Retatrutide (GIP + GLP-1 + Glucagon): ~24%+ weight loss in Phase 2 studies Common side effects were similar to other GLP-1based therapies and included nausea, vomiting, diarrhea, constipation, and abdominal discomfort, primarily during dose escalation
In the early stages of endurance exercise, physiological responsesincluding sympathetic nervous system activation and catecholamine releaseelevate cardiac output to meet the demands of exercising organs (43)
In some embodiments, the amount of thermoreversible polymer (e.g., pluronic F127) in any formulation described herein is about 12% of the total weight of the formulation
The sublingual mucosa allows direct absorption into systemic circulation without gastric acid exposure
